November 29, 2021
17:24
–
The American company Pfizer is developing a vaccine against the latest strain of COVID-19 Omicron, said its CEO Albert Burla, the BBC reported.
Everything on the topic:
Omicron – the new coronavirus variant 48
–According to the head of the company, the existing drugs at the moment may be less effective in preventing this type of coronavirus infection. “New vaccines are needed in this regard,” he added.
“We started the process of creating the new vaccine on Friday. Then we modeled the DNA template of the new strain, which is the first step towards creating a means of protection against COVID-19. I think we will have the first results in less than 100 days, “Burla said.
For his part, the CEO of another developer of a vaccine against coronavirus infection – the US company “Modern” Stefan Wensal said that it takes at least two weeks to determine how effective the drugs currently available to the world are relation to Omircon. “That’s probably why it could be months before the new product is released en masse,” he said.
